Les Viagra kaufen deutsche apotheke produits viennent de Chine. Ce qui Donde comprar priligy peru militerait pour ne pas les exclure des recherches. PRÈS DE Online apotheke schweiz cialis 700 PARTIES CIVILES Le conseil de M. Il Precio viagra arequipa faut ajouter une piste sociétale. A El viagra se puede comprar sin receta medica Strasbourg, la démonstration était implacable. Osman, Comprar viagra fiable qui renvoie aux travaux du tabacologue M. Pas Pris pa viagra danmark d horaires fixes de lever, de repas, de coucher. Restait Kopa cialis pa faktura à en établir le montant. Je suis Se vende la viagra sin receta heureuse qu il ait pu faire ce constat-là. Seule une Precio viagra arequipa alliance peut les résoudre. Ce Pris viagra apotek chiffre est appelé à augmenter, indique ADI. Ce qui Cialis billigt sverige a accéléré les choses. D Donde comprar cialis barcelona autres l accusent d avoir protégé les médecins. Ce Ou acheter du viagra a paris sans ordonnance ne fonctionne pas ainsi partout. Il Venta de cytotec en cali colombia ne faut pas nous prendre pour des imbéciles. Elle provoque Pris pa viagra danmark des troubles moteurs et sensitifs. Le Kop viagra postforskott recul est de 3 %, à 2,1 milliards d euros. Un Donde comprar priligy colombia tabou est brisé.

Rock Star Speakers

Click on a person to read their bio.

Opening Keynote

Carol Gallagher, Frazier Healthcare

Alternative Investment Platforms

Audrey Jacobs, OurCrowd

David Coats, Correlation Ventures

Howard Lindzon, StockTwits

Scott Stanton,Morrison and Foerster LLP

Brain Mapping

Ralph Greenspan, Associate Director, Kavli Institute for the Mind and Brain, UC San Diego

Casimir Wierzynski, Engineer, Qualcomm, Inc.

Active Lifestyle

Lisa Freedman, SD Sport Innovators

Dr. Chris Wahl, UC San Diego Health System

Steve Stoloff, VAVi, Inc.

John Lee, Action Sports & Olympics Wasserman Media Group

Closing Keynote

Thomas H. Lee, Stanford

Carol Gallagher, Venture Partner, Frazier Healthcare

Dr. Gallagher joined Frazier Healthcare’s life science team in October of 2013 as a Venture Partner. Prior to Frazier, Dr. Gallagher was President and CEO of Calistoga Pharmaceuticals, a Frazier-founded company based on a set of novel, preclinical assets spun out of Icos Pharmaceuticals. Dr. Gallagher together with an experienced team she helped to build, advanced a first-in-class product (CAL-101, now called idelalisib) through definitive, proof-of-concept studies in patients with certain lymphomas and leukemias. These efforts ultimately led to the acquisition of Calistoga by Gilead Sciences in 2011 for a total consideration of $600 million. Dr. Gallagher currently serves on several biotech boards, including AnaptysBio and Atterocor, both of which are Frazier portfolio companies. Dr. Gallagher attended Vanderbilt University and received Bachelor of Science and Doctor of Pharmacy degrees from the College of Pharmacy at the University of Kentucky. She started her career at Eli Lilly and Company and held roles of increasing responsibility with Amgen, Agouron/Pfizer, Biogen Idec, CancerVax and Anadys Pharmaceuticals.

Audrey Jacobs, VP Business Development, OurCrowd

Audrey brings 20 years’ experience in global strategic marketing firms to build businesses and their brands. OurCrowd is the world’s leading equity crowdfunding platform that gives accredited investors an innovative, new way to find and invest in startups. Since its inception in February 2013, OurCrowd investors have invested over $34M into 33 portfolio companies. Their investor community spans 20 countries and collectively commands an expansive set of connections and skills, helping their portfolio companies to grow.  OurCrowd has allowed individuals to invest alongside top-tier venture capital firms like  Horizon Ventures, Jerusalem Venture Partners, Cedar Fund, Khosla Ventures, Carmel, Index, Accel, Israel Cleantech Ventures, Aleph Fund, Pontifax, and others. Jon Medved, one of Israel’s most well-known venture capitalists, created OurCrowd to solve a traditional dilemma for angel investors. Angels have the flexibility and freedom to choose their own deals and are not forced to make a large upfront commitment as they would in a venture fund. However, venture funds have access to the best deal flow and work with professional diligence teams, and they regularly invest on better legal terms than angels are able to. OurCrowd solves this dilemma by providing angels an online platform where a professional diligence team has sourced and negotiated deals, publishing them online only after OurCrowd has already invested its own money. Once published online, these deals are open for investors to browse through and select from.

David Coats, Founder and Managing Director, Correlation Ventures

As a founder and Managing Director of Correlation Ventures, David helps lead the firm, including managing its Life Science and Clean Tech investment practices. David created the original vision for Correlation, driven by the opportunity to offer entrepreneurs and other VCs a better co-investment option and to pioneer the use of predictive analytics in venture capital. David began his venture capital career in 1997. Prior to Correlation, David was a Managing Director of Hamilton BioVentures, an early-stage venture capital fund. As head of Hamilton’s Life Science team, David served on the Board of Directors of such companies as PhotoThera, Transcept (NASDAQ: TSPT), and Egea Biopharmaceuticals (Acquired by Johnson&Johnson). Previously, David was a Venture Partner at Windamere Venture Partners and President of Forge Medical Ventures, an early-stage incubator funded by Enterprise Partners, Mayfield Fund and Johnson & Johnson Development Corporation. David was the Founder of Spine Wave, a venture-funded medical device company and Director of Business Development of UroMed Corporation (URMD), a venture-funded startup that raised several rounds of venture capital and completed a public offering. David received an M.B.A. from the Harvard Graduate School of Business Administration and graduated Summa Cum Laude with a B.S. in Biology from Princeton University.

Howard Lindzon, Founder and CEO, StockTwits

Howard Lindzon is co-founder and Chairman of StockTwits® – a social network for traders and investors to share real-time ideas and information. StockTwits was recently named “one of the top 10 most innovative companies in web” by FastCompany and one of the “50 best websites” by Time magazine.Mr. Lindzon has more than twenty years experience in the financial community acting in both an entrepreneurial and investing capacity. With a unique vision for starting and successfully managing innovative companies, he is the General Partner of Social Leverage, a holding company that invests in early stage web businesses. Howard continues to manage a hedge fund he started in 1998. He created Wallstrip, and more than 400 original web video shows, which was purchased by CBS Corp. in 2007. He is an active angel with many success angel investments including: Rent.com, (purchased by Ebay in 2005 for $415 million), Golfnow.com (purchased by Comcast in June 2008), and Lifelock (lead investors include Bessemer Venture Partners and Kleiner Perkins Caufield & Byers).

Scott Stanton, Morrison and Foerster LLP

Scott Stanton has significant experience in mergers and acquisitions, securities offerings, and many other corporate matters. Mr. Stanton serves as primary outside counsel to a number of public and private companies, and he regularly represents boards of directors and board committees in complex corporate governance matters. He has developed a deep expertise in SEC reporting and corporate governance matters that enables him to provide expert and practical advice to a broad range of companies in industries such as software, medical devices, life sciences, semiconductors, consumer goods and defense. Scott Stanton is recommended as a leading lawyer by Legal 500 2012-2013, Best Lawyers in America 2007 – 2014, and Super Lawyers 2008 – 2013. He is a member of the Board of Directors of the Corporate Directors Forum. Mr. Stanton served as Chair of the firm’s global Corporate Practice Group from 2010 – 2013.

Ralph Greenspan, Associate Director, Kavli Institute for the Mind and Brain, UC San Diego

Dr. Ralph J. Greenspan has worked on the genetic basis of behavior and brain function in fruit flies (Drosophila melanogaster) almost since the inception of the field, studying with one of its founders, Jeffery Hall, at Brandeis University in Massachusetts, where he received his Ph.D. in biology in 1979.  He is currently Director of the Center for Brain Activity Mapping of the Kavli Institute for Brain and Mind at the University of California San Diego, and Professor in the Division of Biology’s Neurobiology Section and the Dept. of Cognitive Science.  Dr. Greenspan’s research includes studies of the consequences of mutations and localized genetic alterations in the nervous, molecular identification of genes causing naturally occurring variation in behavior, and the genetic analysis of fruit fly sleep and attention.  His current research addresses large-scale network interactions pertaining to the action of genes and neurons.  In 2011, he was one of the small team of scientists that produced the white paper for the White House Office of Science and Technology Policy that eventuated in the  BRAIN Initiative.  In addition to research papers, he has authored:  Fly Pushing: The Theory and Practice of Drosophila Genetics, , An Introduction to Nervous Systems, and How Genes Influence Behaviour (with Jonathan Flint and Ken Kendler).

Casimir Wierzynski, Engineer, Qualcomm, Inc.

Casimir Wierzynski is the Systems-Neuroscience lead for the Zeroth(™) project at Qualcomm Research. Immediately prior to joining Qualcomm in 2012, Cas was a Beckman Fellow at Caltech, performing research on memory consolidation using in vivo electrophysiology in freely behaving rats. Before switching to neuroscience, Cas was a Vice President at Goldman Sachs & Co in fixed-income derivatives trading. Cas received a BS and MS in electrical engineering at MIT, a BA in mathematics at Cambridge University as a British Marshall Scholar, and a PhD from Caltech in computation and neural systems, where he received the Ferguson Prize in 2009 for the best Ph.D thesis in Biology.

Lisa Freedman. Executive Director of SD Sport Innovators

With over 20 years experience planning and producing events in the Sports and Active Lifestyle Industry, Lisa serves as Executive Director of SD Sport Innovators (SDSI). SDSI, based in San Diego, is a non-profit, business accelerating organization connecting people, products and companies to drive the growth of Southern California’s vibrant sports economy. SDSI offers elite level networking and innovative programs and services for start-ups, mature companies and service providers. Services include mentoring, education and capital funding opportunities for start-ups; best practice collaboration, access to new technology, and public policy advocacy for mature companies; as well as deal flow to service providers and the Southern California Investment Community. Lisa joined SDSI over two years ago and leads the team in fulfilling the organization’s mission. Her experience in business strategy and development, operations management and fiscal planning have helped to grow SDSI’s membership, created and implemented new programs and business strategies, put SDSI’s business operations and financials on a path to success and helped to take SDSI’s business mentoring program, Springboard, to a new level. She enjoys working with such a unique organization and it’s dynamic staff, board and mentors. Most importantly, she loves seeing early stage businesses launch, mid level and mature companies continue to grow and enjoys directing deal flow for all those engaged in the organization and industry. Lisa was born and raised in Atlanta, Georgia, moved to California for college at UC Santa Barbara and has been calling San Diego home for ten years.

Dr. Christopher Wahl, Associate Professor and Chief of Sports Medicine, UC San Diego Health System, Department of Orthopedic Surgery

Dr. Wahl is passionate about treating elite and recreational athletes and is nationally known for his expertise in the treatment of complex knee and shoulder injuries.  In 2013, Dr. Wahl was named the head team physician for the San Diego Chargers. Prior to joining UC San Diego Health System, Dr. Wahl served as team physician for many University of Washington sports teams, including football, men’s basketball, volleyball, softball, gymnastics and tennis. As part of an American Orthopedic Society for Sports Medicine traveling fellowship, he visited many sports facilities and hospitals throughout South America.  Dr. Wahl completed his residency training and earned his medical degree from Yale University. He completed a sports medicine and shoulder surgery fellowship at the prestigious Hospital for Special Surgery in New York City. He then went on to complete a trauma fellowship in Germany and Switzerland as an A.O. John Border Traveling Trauma Fellow.  In addition to his work with athletics, Dr. Wahl has a national reputation as a skilled surgeon, inspirational teacher and compassionate doctor, and has been named a “Top Doctor” by San Diego Magazine in orthopedics and sports medicine surgery. Dr. Wahl enjoys cycling, sailing, running, surfing and skiing with his wife and their three young children.

Steve Stoloff. CEO VAVi, Inc.

Steve Stoloff, CEO of VAVi, is a sports innovator who brings fun to life. VAVi is the largest organizer of adult social sports leagues in Southern California and is a leading producer of nationally-touring 5k obstacle races and fun runs. Over 250,000 people per year participate in VAVi activities, and with signature events like the Del Mar Mud Run and Ridiculous Obstacle Challenge, VAVi offers something for everyone.In addition to offering sports leagues and large-scale events, VAVi also provides an experiential marketing platform for brands to reach active young professionals aged 21-40. VAVi provides the perfect opportunity for a large national brands to build a grassroots connection with a highly targeted and engaged audience.
Steve is also active on many non-profit boards, including San Diego Sports Innovators and the Sport and Social Industry Association, an organization that represents 70 sports clubs nationwide with a participant base of over 1.2 million active young professionals.

John Lee. Senior Director, Action Sports & Olympics, Wasserman Media Group

A proven brand builder that has bridged the gap between corporate society and the hard-core gen y consumer, John Lee has developed key global insight into connecting brands with youth culture and lifestyle for the past 20 years. He lives inside the market and thinks outside of the box.
Currently, John is a Senior Director at Wasserman Media Group managing the consulting group and its clients of the Action Sports and Olympic division consisting of brand analysis, ideation, planning, strategic development, and marketing execution.
Prior to that, John was the GM of Action Sports/Tastemaker for the consumer electronics brand SOL REPUBLIC. He is attributed to launching the emerging brand as well as initiating a retail sales strategy in those channels. John was also a partner and founder of a full-service boutique marketing agency called CUE Projects with a credible client roster: Monster Cable, Beats by Dr. Dre, Continental Tire, General Tire, Creatures of Leisure, K5 Boardshops, Penny Skateboards, Volcom, and Filtrate Eyewear.
While working as the Global Sports Marketing Director for Monster Energy, John was an integral player in building the Monster Energy brand which exploded utilizing action sports as a catalyst showcasing the iconic the green “M” claw. The phrase “lifestyle in a can” pretty much sums up the mantra of the brand. John’s career has also been comprised of vast brand building experience where he has held key executive positions for brands such as Spy Optic, Rip Curl, and On A Mission.

Dr. Sargeant, sixth Chief Counsel for Advocacy of the U.S. Small Business Administration’s Office of Advocacy

Dr. Winslow Sargeant is the sixth Chief Counsel for Advocacy of the U.S. Small Business Administration’s Office of Advocacy, appointed by President Obama August 19, 2010. The Office of Advocacy is an independent voice for small business within the federal government with a mission of encouraging policies that support small business start-up, growth, and development. As chief counsel, Dr. Sargeant directs Advocacy’s operations, which include conducting research on the U.S. small business sector, advocating for small businesses within the federal government’s agencies and rulemaking processes, reaching out to regional and state small business advocates and policymakers, and fostering public awareness of small business contributions and concerns. He received his PhD in electrical engineering in 1995, and later co-founded Aanetcom, a “fabless” semiconductor integrated circuit design company. In March 2000, Aanetcom was acquired by PMC-Sierra, a publicly traded company.

Thomas Lee, MTO Director, DARPA; Professor of Electrical Engineering, Stanford University

Since 1994, Professor Lee has been a Professor of Electrical Engineering at Stanford University where his research focus has been on gigahertz-speed wireline and wireless integrated circuits built in conventional silicon technologies, particularly CMOS. He is an award winning writer, authoring numerous books including The Design of CMOS Radio-Frequency Integrated Circuits (now in its second edition), and Planar Microwave Engineering, both with Cambridge University Press. He served for a decade as an IEEE Distinguished Lecturer of the Solid-State Circuits Society, and has been a DL of the IEEE Microwave Society as well. Tom cofounded Matrix Semiconductor (acquired by Sandisk in 2006) and is the founder of ZeroG Wireless. In early April of 2011 he was awarded the Ho-Am Prize in Engineering (colloquially known as the “Korean Nobel”).